Drug Promotion - What We Know, What We Have Yet to Learn - Reviews of Materials in the WHO/HAI Database on Drug Promotion - EDM Research Series No. 032
(2004; 102 pages) View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentExecutive summary
Open this folder and view contentsIntroduction
Close this folderReview 1. What attitudes do professional and lay people have to promotion?
View the document1.1 Attitudes do not necessarily match behaviour
View the document1.2 Studies of the prevalence of different attitudes to promotion (excluding direct-to-consumer advertising)
View the document1.3 Do trainers and trainees think that sales representatives should be banned during medical training?
View the document1.4 Do doctors think they have enough training to deal with sales representatives?
View the document1.5 Do doctors think that sales representatives have a valuable role in medical education?
View the document1.6 What do health professionals think about the quality of the information provided by sales representatives and advertisements about drugs?
View the document1.7 What do other groups of people think of promotional information?
View the document1.8 What are doctors’ views of pharmaceutical company support of conferences and speakers?
View the document1.9 Do trainee doctors plan to see sales representatives in their future practice?
View the document1.10 What are professionals’ and patients’ attitudes to the appropriateness of gifts?
View the document1.11 Do health professionals feel that discussions with sales representatives affect prescribing?
View the document1.12 Do people feel that accepting gifts influences prescribing?
View the document1.13 Ethics and promotion
View the document1.14 Attitudes to direct-to-consumer advertising of prescription drugs
View the document1.15 Studies of differences in attitudes to promotion (excluding DTCA)
View the documentSummary of conclusions
View the documentDirections for future research
Open this folder and view contentsReview 2. What impact does pharmaceutical promotion have on attitudes and knowledge?
Open this folder and view contentsReview 3. What impact does pharmaceutical promotion have on behaviour?
Open this folder and view contentsReview 4. What interventions have been tried to counter promotional activities, and with what results?
View the documentFinal conclusions
View the documentReferences
 

1.6 What do health professionals think about the quality of the information provided by sales representatives and advertisements about drugs?

Thirty-two per cent of the psychiatry trainees surveyed by Hodges agreed that sales representatives provide useful and accurate information on new drugs (25% for established drugs)4. Fifty-eight per cent of family medicine residents in Sergeant et al.’s study5 felt that the literature provided by sales representatives was useful.

Ninety-two per cent of the Canadian doctors surveyed by Strang et al.13 felt that sales representatives had product promotion as their major goal, and 80% felt they over-emphasised medicines' effectiveness. Forty-seven per cent of the doctors in Eaton and Parish’s study19 felt that they were not able to obtain an unbiased assessment of a newly introduced drug. Most of them felt that most drug information was too commercial and therefore biased.

In a New Zealand study, Thomson et al.20 found that 58 out of a sample of 67 doctors saw sales representatives. In response to an open-ended question about why, 56 of them gave a reason related to learning about new or existing products. The director of the Pharmaceutical Manufacturers’ Association of New Zealand described a survey of doctors, in a letter to the editor of the New Zealand Medical Journal21. Without giving methodological details, he claimed that most New Zealand doctors felt that sales representatives are a good source of information about drugs and recognise practitioners’ information needs, but are over-biased towards their own products.

In contrast, only 16% of UK GPs surveyed by Hayes et al. found visits by sales representatives to be educationally valuable18. University and community practice doctors surveyed by Shearer et al.22 rated direct mail, journal advertising and detailers as the three least reliable sources of drug information. Doctors in community hospitals ranked the representatives they saw higher than university hospital doctors ranked those reps whom they saw. Whelan et al.23 report that staff members in a family medicine residency training programme in Canada did not rate sales representatives as a very useful source of information in response to drug information questions. They rated them poorly on all aspects: frequency of use, availability, ease of use, understandability, helpfulness, extensiveness, and how much confidence they had in them. Among Cockerill and Williams’ Ontario pharmacists24, a minority of the respondents (25%) said sales representatives were an important source of information, while only 17% thought advertisements and promotional literature were. Drug sales representatives were never mentioned as sources of information for the complex clinical case studies used by Boerkamp et al.25. The majority of psychiatrists shown advertisements for psychotropics by Lion et al.26 did not find them attractive or informative.

Sixty-eight per cent of doctors working in a Turkish city surveyed by Güldal and Semin27 thought the information provided by representatives was unreliable. Ninety-four per cent felt a reliable source of information about drugs, other than pharmaceutical companies, was needed.

Benseman28 found that the 45 New Zealand doctors he surveyed expressed varying degrees of anger and frustration at the waste involved in the material they were sent by drug companies. Almost all felt that company material was biased and should not be taken at face value. However they preferred drug company sponsored journals to academic journals, because they found them more relevant to general practice.

Mackowiak et al.29 surveyed a small convenience sample of US community pharmacists and a small sample of pharmacy students about advertisements for over-the-counter drugs in pharmacy journals. In the USA, advertisements for over-the-counter medicines are regulated by the Federal Trade Commission. They must be truthful and not misleading. This is a lower standard than that enforced for prescription drugs. Around half the pharmacists, and students, surveyed by Mackowiak regarded the advertisements they were shown as misleading and not truthful. However they also reported high levels of reliance on them. Most respondents (90% of pharmacists and 81% of students) thought regulations for over-the-counter products should be the same as prescription products.

In a study of health care providers in Africa30, commissioned by the International Federation of Pharmaceutical Manufacturers Associations and the US Pharmaceutical Manufacturers’ Association, 95% of those who received company-provided information reported finding it helpful. The design of this study is not well described.

CONCLUSION: Doctors’ opinions on the usefulness of information from drug companies vary but most believe that such information is biased.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014